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Abstract
G protein-gated inwardly rectifying potassium (GIRK) channels play an important role in regulating neuronal excitability.
Sorting nexin 27b (SNX27b), which reduces surface expression of GIRK channels through a PDZ domain interaction, contains
a putative Ras-association (RA) domain with unknown function. Deleting the RA domain in SNX27b (SNX27b-DRA) prevents
the down-regulation of GIRK2c/GIRK3 channels. Similarly, a point mutation (K305A) in the RA domain disrupts regulation of
GIRK2c/GIRK3 channels and reduces H-Ras binding in vitro. Finally, the dominant-negative H-Ras (S17N) occludes the
SNX27b-dependent decrease in surface expression of GIRK2c/GIRK3 channels. Thus, the presence of a functional RA domain
and the interaction with Ras-like G proteins comprise a novel mechanism for modulating SNX27b control of GIRK channel
surface expression and cellular excitability.
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Introduction
G protein-gated inwardly rectifying potassium (GIRK or Kir3)
channels have been implicated in the pathophysiology of diseases
such as epilepsy, Down’s syndrome, and drug addiction [1]. Like
other inwardly rectifying K+ channels, GIRK channels conduct
outward potassium current near the resting membrane potential,
thereby hyperpolarizing the cell and decreasing membrane
excitability. Stimulation of G protein-coupled receptors (GPCRs)
that couple to pertussis toxin-sensitive G proteins (Gai/o family)
activates GIRK channels through G protein Gbc subunits [2–5].
Four mammalian GIRK subunits are expressed in the brain,
GIRK1, GIRK2, GIRK3 and to a lesser extent GIRK4. These
subunits assemble into heterotetramers of primarily GIRK1/2,
GIRK1/3 or GIRK2/3, and homotetramers of GIRK2 [1].
Neurotransmitters, such as GABA, serotonin and adenosine,
stimulate their cognate GPCRs and drive the G protein-dependent
activation of GIRK channels, leading to inhibition of neuronal
activity [6]. Despite their importance in regulating neuronal
excitability, little is known about intracellular trafficking pathways
and proteins that control expression of GIRK channels.
We recently demonstrated that sorting nexin 27 (SNX27)
regulates GIRK channels through a PDZ domain interaction
[7,8]. SNX27 is a member of a large family of sorting nexins
(SNXs) that are classified by the presence of lipid-binding phox-
homology (PX) domain [9]. Sorting nexins have been identified
across different phyla, with 33 different mammalian SNXs [9].
This rapidly expanding family of cytoplasmic proteins is important
for regulating protein trafficking [9]. For example, SNX9
participates in the formation of the narrow neck of endocytic
vesicles before scission occurs [10], SNX13 controls trafficking of
the G protein as subunit [11], SNX3 is involved in neural
development [12], and SNX17 is involved in trafficking of the
amyloid precursor protein (APP) implicated in Alzheimer’s disease
[13]. SNX27 associates with a variety of signaling proteins,
including GIRK channels [7,8], cytohesin-associated scaffolding
protein (CASP) [14], 5-HT4a receptors [15], b2 adrenergic
receptors [16], NMDA receptors [17], diacylglycerol kinase zeta
(DGKf) [18] and amyloid precursor protein (APP) [19]. SNX27
protein has been detected in synaptosomes purified from mouse
cortex [20], rat hippocampal neurons [7] and lymphocytes [14],
and exists in two splice forms, SNX72a and SNX27b [21].
Interestingly, SNX27b may provide a link between drugs of abuse
and changes in neuronal excitability [21]. Thus, SNX27 plays an
important role in signal transduction and protein trafficking.
SNX27 has three functional domains; PDZ (PSD95/Disc large/
Zona occludens), PX (Phox Phagocytic oxidase domain) and RA
(Ras-association) domains. The PX domain binds specifically to
PI(3)P and targets SNX27 to the early endosomes (EE) [8]. The
PDZ domain mediates a direct protein-protein interaction with a
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Class I PDZ binding motif located in the C-terminal domain of
target proteins [7,8,15–19]. For GIRK channels, the PX and PDZ
domains are essential for targeting GIRK3-containing channels to
the early endosomes and redirecting away from the plasma
membrane, thereby reducing surface expression and producing
smaller GIRK currents [7,8]. However, the role of the RA domain
in the SNX27b-dependent regulation of GIRK channel function
and neuronal excitability is largely unknown. In general, the RA
domain is hypothesized to be involved in facilitating the exchange
of GTP for GDP on small Ras-like G proteins [22]. Recently, the
carboxyl terminal fragment of SNX13, SNX27 and SNX31,
which contains the RA domain, was reported to associate with
activated H-Ras in an in vitro binding assay [19]. The functional
consequence of this interaction remains poorly understood.
In the present study, we investigated the function of the RA
domain in the SNX27b-dependent regulation of GIRK channels.
We provide new evidence that a functional RA domain is essential
for SNX27b control of trafficking and down-regulation of GIRK3-
containing channels. These findings provide the first clues into a
pathway for regulating SNX27b function in the brain, establishing
a possible new link between Ras signaling and neuronal
excitability.
Results and Discussion
We have previously observed that overexpression of SNX27b
leads to accumulation of GIRK3-containing channels in early
endosomes and subsequent reduction in surface expression of
GIRK channels (Figure 1A) [8]. To investigate the function of the
SNX27b RA domain, we first constructed a mutant of SNX27b
that lacks the RA domain (SNX27b-DRA) (Figure 1B). We
examined the functional effect of SNX27b by measuring the
amplitude of GABAB receptor-activated GIRK currents in
HEK293T cells expressing GIRK2c/GIRK3 channels along with
GABAB1 and GABAB2 receptors. Coexpression of SNX27b with
GIRK2c/GIRK3 channels significantly reduced the amplitude of
GABABR-activated currents (IBaclofen) measured with a saturating
concentration (100 mM) of the GABABR agonist baclofen (–
10 pA/pF vs –41 pA/pF for control, Figure 1C, 1D). In contrast
to SNX27b, expression of SNX27b-DRA did not significantly
change IBaclofen (–55 pA/pF) with GIRK2c/3 channels
(Figure 1C, D). Similarly, SNX27b-DRA did not significantly
alter IBaclofen for HEK293T cells expressing GIRK1/3 channels
(Figure 1D), in contrast to previous studies where wild-type
SNX27b consistently reduced GIRK1/3 currents [7,8,23]. Thus,
removal of the RA domain appeared to interfere with the ability of
SNX27b to regulate GIRK3-containing channels in HEK293T
cells.
To determine whether SNX27b-DRA continued to associate
with GIRK2c/3 channels, we next examined the localization of
GIRK2c/3 channels in the presence of SNX27b-DRA. We used
bimolecular fluorescence complementation (BiFC), a novel meth-
od for monitoring the expression pattern of GIRK2c/3 hetero-
tetramers (Figure 2A) [24]. BiFC involves genetically fusing non-
fluorescent, complementary fragments of YFP to two different
proteins. When the two proteins interact, as would be the case for
two GIRK subunits (e.g. GIRK2c and GIRK3), the two non-
fluorescent fragments associate and reconstitute a functional
fluorescent protein [24]. CYFP was fused to the N-terminal
domain of GIRK2c (CYGIRK2c) and NYFP was fused to the N-
terminal domain of GIRK3 (NYGIRK3) (Figure 2A), allowing the
unencumbered C-terminal domains of the channels to freely
associate with SNX27b. Coexpression of CYGIRK2c and
NYGIRK3 led to fluorescently labeled proteins that expressed
diffusely in the cytoplasm and functionally coupled with GABAB
receptors on the plasma membrane (Figure 2A,B Control),
similar to a previous study [25]. Expression of SNX27b with
CYGIRK2c/NYGIRK3 induced puncta of fluorescence in the
cytoplasm, typical of endosomal localization (Figure 2Bii) [7,8].
Expression of SNX27b-DRA, on the other hand, resulted in a
diffuse pattern of CYGIRK2c/NYGIRK3 fluorescence
(Figure 2Biii), similar to that observed in control cells. Thus,
deleting the RA domain appeared to disrupt the interaction of
SNX27b-DRA with GIRK2c/GIRK3 channels, altering the
ability of SNX27b to control the trafficking and surface expression
of GIRK channels. This result was unexpected since SNX27b-
DRA contains intact PDZ and PX domains, which would be
expected to associate with the PDZ motif of GIRK2c/3 and
endosomal PI(3)P, respectively. Introducing a mutation (Y51L) in
the PDZ domain of SNX27b known to disrupt PDZ binding [7]
led to a similar diffuse pattern of CYGIRK2c/NYGIRK3
fluorescence (Figure 2Biv), suggesting a potential defect in
PDZ binding when the RA domain is deleted. To rule out the
possibility that deleting the RA domain simply altered the
expression of SNX27b itself, we examined the localization of
YFP-tagged SNX27b-DRA (SNX27b-DRA-YFP). Discrete puncta
of green fluorescence typical of endosomal localization were
observed in HEK293T cells expressing either SNX27b-YFP or
SNX27b-DRA-YFP (Figure 2C), indicating that SNX27b-DRA
is expressed and targeted properly.
To investigate the possible mechanism underlying the inability
of SNX27b-DRA to regulate GIRK channel expression, we
examined the effect of selective point mutations in the RA domain.
Previously, RA domains have been shown to interact with Ras-like
proteins [19,26]. Examination of a high resolution structure
complex of the Ras and the Ras-interacting domain (RID) of Ral
or Raf, which is homologous to the RA domain of SNX27b,
revealed several basic amino acids (R20, K32, K52) in the RID
that electrostatically attract and form hydrogen bonds with acidic
residues in Ras-Switch II (e.g. D33) [27–30] (Figure 3B). We
aligned the sequence of SNX27b RA domain with the RID
domains of RalGDS and Raf proteins (Figure 3A) and identified
four basic amino acids in the putative RID of SNX27b that might
be involved in binding Ras (R276, R288, K291, K305). We
created three mutants, R276A, R288A/K291A and K305A
SNX27, which neutralized these basic amino acids, and examined
their effects on the expression pattern of CYGIRK2c/NYGIRK3
channels using BiFC (Figure 3C). Similar to SNX27b-DRA, each
point mutation appeared to impair the ability of SNX27b to
induce punctate fluorescence for CYGIRK2c/NYGIRK3 channels
(Figure 3C). Focusing on SNX27b-K305A, immunostaining
revealed partial co-localization with the early endosomal marker,
early endosome antigen 1 (EEA1), (Figure 3D), similar to wild-
type SNX27b [8]. Thus, the PX domain which targets SNX27b to
the early endosome appears to be unaffected by the K305A
mutation [19]. We then examined the effect of the K305A
mutation in SNX27b on GIRK2c/3 channels expressed in
HEK293T cells. Similar to SNX27b-DRA, SNX27b-K305A did
not reduce IBaclofen for GIRK2c/GIRK3 channels (Figure 3E).
To examine whether the K305A mutation in the RA domain
interfered with the association of SNX27b with H-Ras, we
performed a pull-down experiment using recombinant proteins
expressed and purified from E. coli (Figure 4A, 4B) [19]. A GST
fusion protein containing the C-terminal region of SNX27b
(Asp272-Tyr526) that includes the RA domain (GST-RAWT)
pulled down a His8-tagged constitutively active form H-Ras, His8-
H-RasG12VCA (Figure 4C). By contrast, GST-RAK305A showed
weak or no association with His8-H-RasG12VCA (Figure 4C). The
RA Domain Is Critical for SNX27 Function
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Figure 1. Deletion of RA domain in SNX27b impairs functional regulation of GIRK channels. A, Cartoon shows model of GIRK channels
regulation by SNX27b. GIRK channels recycle through endosomal compartments. SNX27b associating with GIRK2c/3 channels in the early endosome
(EE) reduces plasma membrane expression (PM) by targeting some channels to the late endosome (LE). B, SNX27 contains three functional domains;
PDZ, PX and RA. GIRK2c and GIRK3 contain a C-terminal PDZ binding motif (-E(S/N)ESKV). C, Examples of baclofen-induced (100 mM) and Ba2+-
sensitive (1 mM Ba2+) currents in HEK293T cells transfected with cDNA for GABAB1a/B2 receptors, GIRK2c/GIRK3 and either control vector, SNX27b or
SNX27b-DRA. Agonist-independent basal currents are revealed by inhibition with 1 mM Ba2+. D, Average baclofen-induced current densities (IBaclofen)
for control (–41.365.2 pA?pF21, n = 8), SNX27b (–11.063.6 pA?pF21, n = 8) and SNX27b- DRA (–55.968.2 pA?pF21, n = 13) with GIRK2c/GIRK3. E,
Average IBaclofen for control (–15.763.6 pA?pF
21, n = 6) and SNX27b-DRA (–18.664.9 pA?pF21, n = 5) with GIRK1/GIRK3 (**P,0.05, one way ANOVA
followed by Bonferroni post hoc test; n.s. – not significant).
doi:10.1371/journal.pone.0059800.g001
RA Domain Is Critical for SNX27 Function
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K305A point mutation consistently reduced by ,75% the
association of the RA domain with H-RasG12VCA (Figure 4D;
n=4). Taken together, these findings raise the possibility that the
interaction of H-Ras with the RA domain is an important step in
the SNX27-dependent regulation of GIRK channels.
To explore this hypothesis further, we examined the effect of a
dominant-negative (S17N) form of H-Ras (H-RasS17NDN). We
hypothesized that H-RasS17NDN would compete for endogenous
Ras and possibly impair the ability of SNX27b to regulate
GIRK2c/3 channels. In HEK293T cells coexpressing GIRK2c/
3 with H-RasS17NDN, IBaclofen was indistinguishable from that in
HEK293T cells coexpressing GIRK2c/3, H-RasS17NDN and
SNX27b (Figure 5B, 5C), suggesting SNX27b regulation of
GIRK channels required activated Ras. Interestingly, expression
of H-RasS17NDN alone not only reduced IBaclofen (Figure 5B, 5C)
but also reduced IBarium compared to control cells (Figure 5E),
Figure 2. Deletion of RA domain in SNX27b affects localization of GIRK2c/3 channels monitored with BiFC. A, Left, Schematic shows
placement of split YFP on GIRK2c and GIRK3. Note the C-terminal domains are free to interact with other proteins. Right, BiFC-tagged GIRK2c/3
channels are functional. Current-voltage plot is shown for CYGIRK2c/NYGIRK3 channels. Baclofen (100 mM) activates and Ba2+ (1 mM) inhibits inwardly
rectifying current. HEK293T cells were transfected with cDNA encoding GABAB1a, GABAB2 and
CYGIRK2c/NYGIRK3. Average baclofen-induced current
densities were –13.266.0 pA?pF21 (n = 3) for CYGIRK2c/NYGIRK3. B, HEK293 cells were co-transfected with CYGIRK2c, NYGIRK3 and either control cDNA
(i), wild-type SNX27b (ii), SNX27b-DRA (deletion of Asp272-Trp358) (iii) or SNX27b-Y51L (a PDZ mutation) (iv). Green fluorescence in images
represents molecular recombination of CYGIRK2c/NYGIRK3 heterotetramers. Coexpression of wild-type SNX27b induced formation of puncta. By
contrast, CYGIRK2c/NYGIRK3 fluorescence was diffuse in the cytoplasm for SNX27b-DRA and for SNX27b-Y51L, similar to control. Inset shows zoom of
boxed area. C, SNX27b-DRA exhibited a pattern of punctate expression similar that of wild-type SNX27b. YFP was fused to the C-terminus of SNX27b
or SNX27b-DRA to directly visualize expression. HEK293T cells were transfected with cDNA for SNX27b-YFP and SNX27bDRA-YFP. Scale bar: 10 mm.
doi:10.1371/journal.pone.0059800.g002
RA Domain Is Critical for SNX27 Function
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suggesting a direct effect of the dominant negative Ras on channel
expression perhaps mediated by endogenous SNX27. Indeed,
Lauffer et al [16] and Cai et al [17] have demonstrated
endogenous expression of SNX27b in HEK293 cells and that
knockdown of SNX27 leads to reduced surface expression of b
adrenergic receptors [16]. Consistent with this, we attempted to
measure endogenous SNX27b in the HEK293T cells and detected
low levels of protein (data not shown). Thus, SNX27 levels may be
tightly regulated where too little or too much SNX27 can interfere
with GIRK trafficking to the plasma membrane.
To learn more about the role of Ras proteins, we examined the
effect of expressing the constitutively active H-RasG12VCA with
GIRK2c/3 in the absence and presence of SNX27. Surprisingly,
H-RasG12VCA alone reduced IBaclofen for GIRK2c/3 currents and
coexpression with SNX27b did not reduce the current further
(Figure S1A). However, H-RasG12VCA did not affect the basal
IBarium for GIRK2c/3 channels, in contrast to the dominant
negative effect of H-RasS17NDN (Figure S1B). Furthermore,
SNX27b reduced IBarium in the presence of H-RasG12VCA. Taken
together, these differences between the dominant-negative and
constitutively active H-Ras forms are consistent with a model
where the dominant negative Ras effect on GIRK2c/3 involves
endogenous SNX27 and the constitutively active form affects other
signaling pathways (e.g. GPCR function). We therefore developed
an alternative strategy to probe the possible effect of the dominant
negative H-Ras by modifying the GIRK channels. Previously, we
identified two variants of GIRK2/3 channels that were not
regulated by SNX27b; GIRK2a, which lacks a PDZ-binding
motif, and GIRK3-RR, which contains two Arginine substitutions
in the C-terminal PDZ motif that selectively disrupt PDZ binding
[7] (Figure 5A). Coexpression of SNX27b with these GIRK2a/
GIRK-RR variants did not lead to smaller receptor-activated
currents [7]. In contrast to wild-type channels, expression of H-
RasS17NDN did not significantly change IBaclofen or IBarium for
Figure 3. K305A point mutation in SNX27b RA domain disrupts functional regulation of GIRK2c/GIRK3 channels. A, Alignment of two
different RA domains: a RID (Ras interacting domain) from RalGDS and a RA domain of RGL, with RA domain of SNX27. Residues implicated in Ras
binding in Raf and RalGDS domains [28–30] are highlighted in red. B, High-resolution structure shows R20, K32 and K52 at the binding interface of
RID and Ras [26]. C, RA domain mutations impair the ability of SNX27b to induce formation of GIRK2c/3 puncta using BiFC. HEK293T cells were co-
transfected with cDNA for CYGIRK2c/NYGIRK3 and either wild-type SNX27b (i), SNX27b-R276A (ii), SNX27b-R288A/K291A (iii) or SNX27b-K305A (iv).
Green fluorescence indicates molecular complementation of CYGIRK2c/NYGIRK3. Scale bar: 10 mm. D, Colocalization of wild-type SNX27b (SNX27b-
YFP; green) and SNX27b-K305A (anti-SNX27; green) with an early endosomal marker (anti-EEA1, green). Scale bar: 5 mm. E, Average IBaclofen currents
for control (–53.469.4 pA?pF21, n = 5), SNX27b (–8.0563.44 pA?pF21, n = 6) and SNX27b-K305A (–52.968.8 pA?pF21, n = 10) with GIRK2c/GIRK3
channels.
doi:10.1371/journal.pone.0059800.g003
RA Domain Is Critical for SNX27 Function
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GIRK2a/GIRK3-RR channels (Figure 5D,E). Taken together,
these results suggest that RasS17NDN interferes with both
endogenously and exogenously expressed SNX27, though addi-
tional experiments are needed to probe the role of endogenous
SNX27b more explicitly using a knockout strategy.
In summary, the RA domain of SNX27b has an unexpected but
important role in modulating SNX27b control of GIRK2c/
GIRK3 trafficking. Our findings contribute to an emerging idea
that endomembrane-associated Ras-like G proteins are capable of
signaling through selective interactions with RA domain-contain-
ing proteins, in addition to their well-known plasma membrane
signaling pathway [31]. The molecular details on the putative
interaction between the RA domain and H-Ras and how it
regulates PDZ binding remain unclear. One possibility is the
complex of H-Ras with SNX27b recruits sorting machinery
required to recycle GIRK channels from the endosome to
lysosome or back to the membrane; the destination being
dependent on the level of SNX27b present in the cell.
Alternatively, the RA domain may regulate PDZ binding through
some unknown mechanism. Interestingly, we demonstrated
previously that the bB-bC loop of the SNX27-PDZ domain is
critical for GIRK3 binding [7], perhaps offering a mechanism for
regulating PDZ binding. Nonetheless, the discovery that the RA
domain is important for SNX27b function could provide a novel
mode for regulating SNX27b function in vivo. SNX27b targets
other proteins in the brain, including the b2 adrenergic receptor
[16], 5-HT4a receptor [15] and NMDAR2C receptor [17]; it will
be interesting to see in the future if the RA domain is important for
SNX27b regulation of these proteins.
Methods
Molecular Biology
For bimolecular fluorescence complementation (BiFC), the N-
terminal half (amino acids 1 to 155) of the yellow fluorescent
protein (NYFP or NY) or the C-terminal half (amino acids 156 to
231) of YFP (CYFP or CY) was cloned into XhoI-XbaI sites of
Figure 4. K305A point mutation in SNX27b RA domain disrupts
interaction with constitutively active H-Ras (H-RasG12VCA). A,
Cartoons of SNX27b, GST fused to SNX27b-RAWT or SNX27b-RAK305A. B,
Coomassie stain shows purified GST, His8-RasG12VCA, GST-RAWT and
GST-RAK305A. C, Western blot using anti-His6 antibody shows His8-
RasG12VCA binding to GST-RAWT but not to GST-RAK305A. C, Quantifica-
tion of pull-down shows consistent decrease in association of GST-
RAK305A mutant with His8-RasG12VCA (assay repeated 4 times).
doi:10.1371/journal.pone.0059800.g004 Figure 5. Dominant-negative H-Ras (H-RasS17NDN) prevents
SNX27b-dependent down-regulation of GIRK channels. A,
Schematic shows GIRK2c and GIRK3 with PDZ-binding motif and
GIRK2a and GIRK3-RR, which lack motifs that interact with SNX27-PDZ
[7]. B, Examples of baclofen-induced (100 mM) and Ba2+-sensitive (1 mM
Ba2+) currents in HEK293 cells transfected with cDNA for GABAB1a/B2,
GIRK2c/GIRK3 and either empty vector (Control), H-RasS17NDN or H-
RasS17NDN plus SNX27b. C, Bar graph shows average IBaclofen for GIRK2c/
GIRK3 alone (–47.768.5 pA?pF21, n = 6), GIRK2c/GIRK3 and H-RasS17NDN
(–22.063.8 pA?pF21, n = 19) or GIRK2c/GIRK3, SNX27b and H-RasS17NDN
(–23.764.7 pA?pF21, n = 16). D, Bar graph shows IBaclofen for control
(GIRK2a/GIRK3-RR alone) (–18.863.0 pA?pF21, n = 10) and GIRK2a/
GIRK3-RR plus H-RasS17NDN (–18.662.0 pA?pF
21, n = 11). E, Bar graph
shows average IBarium for GIRK2c/GIRK3 alone (–27.669.8 pA?pF
21,
n = 6), GIRK2c/GIRK3 and H-RasS17NDN (–7.362.2 pA?pF
21, n = 18) or
GIRK2c/GIRK3, SNX27b and H-RasS17NDN (–7.161.5 pA?pF
21, n = 14). F,
Bar graph shows average IBarium for GIRK2a/GIRK3-RR alone
(22.4960.9 pA?pF21, n = 10), GIRK2c/GIRK3 and H-RasS17NDN
(21.8460.4 pA?pF21, n = 11). **P,0.05, one way ANOVA followed by
Bonferroni post hoc test; n.s. – not significant.
doi:10.1371/journal.pone.0059800.g005
RA Domain Is Critical for SNX27 Function
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pcDNA3.1+ vector (Invitrogen, Carlsbad, CA, USA). The cDNAs
encoding GIRK2c or GIRK3 were subcloned into the XbaI site of
pcDNA3.1(+) in frame with the sequences for NYFP or CYFP as
indicated. The cDNAs for H-Ras (G12V & S17N) were obtained
from Missouri S&T cDNA Resource Center (#RASH0000C0,
http://www.cdna.org) and subcloned into the pHis8-3 vector
downstream of His8 tag sequence. A C-terminal fragment
containing the RA domain of SNX27b (Asp272-Tyr526) was
fused to GST by sub cloning into EcoRI and BamHI sites of
pGEX-2T vector (GE Biosciences). Point mutations were
introduced by site-directed mutagenesis kit (QuikChange II XL,
Agilent) and confirmed by automatic DNA sequencing. SNX27-
DRA construct has an internal deletion encompassing the RA
domain (Asp272-Trp358).
BiFC Experiments
Human Embryonic Kidney 293 (HEK293) cells were grown in
Dulbecco’s modified Eagle’s medium, DMEM (Sigma-Aldrich, St.
Louis, MO, USA) supplemented with 1 mM sodium pyruvate,
2 mM L-glutamine, 100 U/ml streptomycin, 100 mg/ml penicillin
and 10% (v/v) Fetal Bovine Serum (FBS) at 30 or 37uC and in 5%
CO2 humidified atmosphere. HEK293 cells were transiently
transfected with cDNA using Transfectin (BioRad) or Lipofecta-
mine 2000 (Invitrogen), and incubated at 37uC for 24 h and 30uC
for another 24 h, to improve the molecular recombination.
Transfected HEK293 cells were fixed in 1% paraformaldehyde
solution in phosphate buffered saline (PBS) for 10 min, and
washed with phosphate buffered saline (PBS) containing 20 mM
glycine to quench any remaining paraformaldehyde. Cells were
mounted with Vectashield immuno-fluorescence medium (Vector
Laboratories, Peterborough, U.K.) or ProlongGold (Invitrogen,
Carlsbad, CA, USA) and imaged with a Leica TCS-SL or Zeiss
LSM-710 confocal microscope.
Immunocytochemistry
HEK293T cells were fixed in 2% paraformaldehyde in PBS for
10 min, washed with PBS, permeabilized with 0.2% Triton-X in
PBS, blocked with 1% bovine serum albumin (Jackson ImmunoR-
esearch) in PBS/glycine for 1 h at room temperature. Cells were
incubated with mouse anti-early endosome antigen 1 (EEA1; BD
Biosciences) antibody (1:400) or rabbit anti-SNX27 antibody
(1:400) [8] for 1 h, washed and incubated with Alexa 488 or Alexa
647-conjugated secondary antibodies (1:400; Invitrogen) for 1 h at
room temperature. Primary and secondary antibodies were diluted
in the blocking solution. Cells on coverslips were mounted as
described above.
Whole-cell Patch-clamp Electrophysiology
HEK293T cells were transfected with 0.2 mg of each channel
cDNA of GIRK2c, GIRK2a, GIRK1, GIRK3 and/or GIRK3-
RR as indicated for each experiment; and 0.2 mg of each
GABAB1a and GABAB2 and 0.04 mg EYFP using Lipofectamine
2000 (Life Technologies). Whole-cell patch-clamp recordings were
performed 48 h post transfection using borosilicate glass electrodes
(Warner Instruments) with 3–5 MV resistance when filled with the
130 K intracellular solution [(in mM): 130 KCl, 20 NaCl,
5.46 MgCl2, 10 HEPES/Na, pH 7.4, and 5 EGTA/KOH,
2.56 K2ATP and 0.3 Li2GTP; pH 7.4] Extracellular 20K solution
contained (in mM): 156 NaCl, 20 KCl, 2 MgCl2, 0.5 CaCl2, and
10 HEPES/Na, pH 7.4. Macroscopic membrane currents were
recorded using an Axopatch 200B amplifier (Molecular Devices,
CA, USA) amplifier, compensated electronically for cell capaci-
tance and series resistance (70–90%), filtered at 2 kHz with an
eight-pole Bessel filter, digitized at 5 kHz with a Digidata 1200/
1320 A/D interface (Molecular Devices), and stored on a
laboratory computer for offline analysis. (6) Baclofen (Sigma-
Aldrich, CO, USA) was dissolved in dH2O to make a 10 mM
stock and diluted directly in the extracellular solution to 100 mM.
Data were acquired at room temperature (22–25uC) and analyzed
with Clampfit 8.0 (Molecular Devices).
Protein Biochemistry
Proteins were expressed in BL21DE3 strain of E. coli (NEB,
MA, USA). After reaching an optical density OD600nm of 0.6,
protein expression was induced with 400 mM IPTG for 4 hours at
28uC. GST and His8 proteins were purified using glutathione
sepharose beads (GE Healthcare Life Sciences) and Ni-NTA resin
(Qiagen, CA, USA), respectively. Protein pull-down assays were
performed as described by Ghai et al. [19]. Briefly, purified GST
(control) or a GST fused to SNX27-Asp272-Tyr526 (SNX27-
RAD272-Y526) was mixed with His8-H-RasG12VCA for 1 h at room
temperature in pull-down buffer (50 mM Tris, 200 mM NaCl,
1 mM DTT, and 1% IGEPAL-CA630, pH 8.0). Protein-protein
complexes were pelleted by centrifugation using glutathione
sepharose beads, separated on SDS-PAGE gel, transferred to
nitrocellulose and exposed to anti-His6 antibodies for western
detection of His8-H-RasG12VCA.
Statistical and Protein Analyses
Data are presented as mean 6 SEM. Statistical differences were
examined using unpaired Student’s t-test for two groups or one-
way ANOVA with Bonferroni post hoc test for multiple groups.
P,0.05 was considered statistically significant. Protein sequences
were first aligned using ClustalV algorithm in LaserGene
MegAlign software ver.9.0.4 (DNASTAR Inc., WI, USA) and
manually adjusted.
Supporting Information
Figure S1 SNX27b-dependent down-regulation of basal
GIRK2c/GIRK3 channels is maintained in the presence
of constitutively active H-Ras (H-RasG12VCA). A. Bar
graph shows IBaclofen for control (GIRK2c/GIRK3 alone; –
66.467.2 pA?pF21, n = 6) and GIRK2c/GIRK3 plus H-
RasG12VCA (–12.961.8 pA?pF
21, n = 5), GIRK2c/GIRK3 plus
H-RasG12VCA and SNX27b (–9.7561.5 pA?pF
21, n = 7), and
GIRK2c/GIRK3 plus SNX27b alone (–12.463.5 pA?pF21,
n = 9). B. Bar graph shows IBarium for control (GIRK2c/GIRK3
alone; –24.663.0 pA?pF21, n = 6) and GIRK2c/GIRK3 plus H-
RasG12VCA (–23.367.1 pA?pF
21, n = 5), GIRK2c/GIRK3 plus
H-RasG12VCA and SNX27b (–5.7960.9 pA?pF
21, n = 7), and
GIRK2c/GIRK3 plus SNX27b (–4.8461.5 pA?pF21, n = 8).
**P,0.05, one way ANOVA followed by Bonferroni post hoc
test; n.s. – not significant.
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